The Board has determined that new and material evidence has not been received to reopen the claim seeking service connection for the cause of the veteran's death.
The deciding factor: The new evidence does not establish the clinical presence of AML in service or within one year of the veteran's retirement, nor does it indicate that any of his service-connected disabilities caused or substantially contributed to his death.
- Claimed conditions
- Acute Myelogenous Leukemia (AML)
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- July 24, 2006
- Citation
- 0621778
Veterans Law Judge
Decisions by this judge: 952 · Granted: 17% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0621778.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board has determined that the Veteran's cause of death, Acute Myelogenous Leukemia (AML), is related to his in-service exposure to herbicide agents. After considering all evidence and resolving all reasonable doubt in favor of the claimant, service connection for AML due to herbicide exposure is granted.
- Partly granted
The Board denied service connection for various conditions and granted an initial 20 percent rating for right lower extremity deep vein thrombosis, while remanding several other issues.
- Remanded (sent back)
The Board has remanded several issues related to the effective dates and service connection for AML, including a motion to revise the November 2005 rating decision on CUE grounds. The propriety of the January 2022 rating decision regarding the effective date for accrued benefits purposes is also under review.
- Remanded (sent back)
The Board has denied a compensable evaluation for AML with allogenic SCT from August 1, 2018. The appeal is remanded for further consideration of service connection claims related to hiatal hernia, dysphagia (difficulty swallowing), and an acquired mental disorder.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.